ICU Medical (ICUI) Q2 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure
Key numbers
- Reported EPS
- $2.37
- Estimate
- $1.91
- Surprise
- +23.8%
- Revenue (period 2026-06-30)
- $551.7M
- Score at report (before → after)
- 4.7 → 4.4/10
Revenue source: xbrl.
How the report landed
ICU Medical (ICUI) beat the $1.91 estimate with diluted EPS of $2.37 — a large 23.8% upside surprise. TrendMatrix's engine moved from Hold (4.7/10) to Sell at 4.4/10 after the report — the engine's score fell despite the beat.
Where TrendMatrix's rating stands now
TrendMatrix currently rates ICUI Sell at 4.8/10.
4 of the last 4 quarters beat the estimate; this quarter's +23.8% surprise compares with a +22.7% four-quarter average. Next scheduled report: 2026-11-05.
What supports the rating
- Sector modifier (Healthcare): +0.5
- Strong earnings beat streak (4/4)
What argues against it
- Concentration risk — Supplier: single supplier
- Thin upside margin: 7.0%
- V7 low-quality RISK_OFF penalty: -0.5 (Q=4.6)
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $157.26
- Price target
- $168.24
- Stop
- $151.23
- Upside to target
- +7.0%
- Reward-to-risk
- 1.1:1
The stock trades at 135.3× trailing but 16.7× forward earnings — consensus estimates already build in a substantial earnings recovery.
Risk check: RSI 6 — a level conventionally read as oversold.
Model outputs from TrendMatrix’s engine as of 2026-09-11 — shown for context, not personalized investment advice.
ICUI at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Medical Instruments & Supplies
- Market cap
- $4.03B
- P/E (fwd)
- 16.7
- P/E (ttm)
- 135.3
- 52-week range
- $112.50–$192.85
- Off 52-week high
- 18.5%
- RSI (14)
- 6
- Volume vs avg
- 0.74×
- Score today
- 4.8/10